Valsartan, captopril, or both in myocardial infarction.
John H
JH
McAnulty
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use*; D026690:Ethics, Clinical; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D012107:Research Design; D013777:Tetrazoles / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000068756:Valsartan; D018487:Ventricular Dysfunction, Left / Q000209:etiology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D010919:Placebos; D013777:Tetrazoles; D000068756:Valsartan; D002216:Captopril; D014633:Valine